Get started
Author

Jens Henrik Norum

Observed names: J H Norum, J.H. Norum, JH Norum, Jens H. Norum, Jens Henrik Norum, Norum, Jens, Norum, Jens Henrik
Observed institutions: Institució Catalana de Recerca i Estudis Avançats, Universitat Autònoma de Barcelona, Oslo University Hospital, University of Oslo, Karolinska Institutet, Center for Innovative Medicine, Vall d'Hebron Institute of Oncology
ORCID: 0000-0003-2689-7154
Observed ORCID: 0000-0003-2689-7154
OpenAlex ID: A5032459872
Interrogating open issues in cancer precision medicine with patient-derived xenografts
2017 · Annette T. Byrne, Denis G. Alférez, et al. · Nature reviews. Cancer · 658
PDF
Re-definition of claudin-low as a breast cancer phenotype
2020 · Christian Fougner, Helga Bergholtz, et al. · Nature Communications · 178
PDF
GLI1 regulates a novel neuropilin‐2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiation
2013 · Hira Lal Goel, Bryan Pursell, et al. · EMBO Molecular Medicine · 167
Ras-dependent ERK Activation by the Human Gs-coupled Serotonin Receptors 5-HT4(b) and 5-HT7(a)
2003 · Jens Henrik Norum, Kent Hart, et al. · Journal of Biological Chemistry · 117
Regulated Splicing of the α6 Integrin Cytoplasmic Domain Determines the Fate of Breast Cancer Stem Cells
2014 · Hira Lal Goel, Tatiana Gritsko, et al. · Cell Reports · 114
PDF
An Autocrine VEGF/VEGFR2 and p38 Signaling Loop Confers Resistance to 4-Hydroxytamoxifen in MCF-7 Breast Cancer Cells
2008 · Reidun Aesoy, Betzabe Chavez Sanchez, et al. · Molecular Cancer Research · 96
PDF
Molecular cloning of a mammalian nuclear phosphoprotein NUCKS, which serves as a substrate for Cdk1 in vivo
2001 · Anne C. Østvold, Jens H. Norum, et al. · European Journal of Biochemistry · 67
PDF
Lessons learned from the intrinsic subtypes of breast cancer in the quest for precision therapy
2014 · J H Norum, K Andersen, et al. · British journal of surgery · 49
PDF
Endogenous expression and protein kinase A‐dependent phosphorylation of the guanine nucleotide exchange factor Ras‐GRF1 in human embryonic kidney 293 cells
2005 · Jens Henrik Norum, Trond Méthi, et al. · FEBS Journal · 40
PDF
Activation of Adenylyl Cyclase by Endogenous Gs-Coupled Receptors in Human Embryonic Kidney 293 Cells Is Attenuated by 5-HT7 Receptor Expression
2005 · Kjetil Wessel Andressen, Jens Henrik Norum, et al. · Molecular Pharmacology · 39
Erratum: Interrogating open issues in cancer medicine with patient-derived xenografts
2017 · Annette T. Byrne, Denis G. Alférez, et al. · Nature reviews. Cancer · 37
PDF
Claudin-low-like mouse mammary tumors show distinct transcriptomic patterns uncoupled from genomic drivers
2019 · Christian Fougner, Helga Bergholtz, et al. · Breast Cancer Research · 29
PDF
The tankyrase inhibitor G007-LK inhibits small intestine LGR5+ stem cell proliferation without altering tissue morphology
2018 · Jens Henrik Norum, Ellen Skarpen, et al. · Biological Research · 29
PDF
A conditional transgenic mouse line for targeted expression of the stem cell marker LGR5
2015 · Jens Henrik Norum, Åsa Bergström, et al. · Developmental Biology · 12
Karonudib has potent anti-tumor effects in preclinical models of B-cell lymphoma
2021 · Morten P. Oksvold, Ulrika Warpman Berglund, et al. · Scientific Reports · 8
PDF
Epac‐ and Rap‐independent ERK1/2 phosphorylation induced by Gs‐coupled receptor stimulation in HEK293 cells
2006 · Jens Henrik Norum, Hoda Dawood, et al. · FEBS Letters · 7
PDF
B cells and energy metabolism in HER2-positive DCIS: insights into breast cancer progression from spatial-omics analyses
2025 · Helga Bergholtz, Jens Henrik Norum, et al. · Breast Cancer Research · 6
Improved analysis of in vivo drug combination experiments with a comprehensive statistical framework and web-tool
2025 · Rafael Romero-Becerra, Zhi Zhao, et al. · Nature Communications · 5
PDF
GLI1‐induced mammary gland tumours are transplantable and maintain major molecular features
2019 · Jens Henrik Norum, Oliver Frings, et al. · International Journal of Cancer · 4
PDF
The harmonized activities of HER2–HER3 heterodimer and deacetylated FOXA1 evade hormone response by regulating FOXA1 chromatin binding
2025 · Shixiong Wang, Gemma Santacana-Font, et al. · Nucleic Acids Research · 1
PDF
Breast tumors escape endocrine therapy by ER-independent mechanisms triggered by the coordinated activities of HER2/HER3 and deacetylated FOXA1
2020 · Siv Gilfillan, Shixiong Wang, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Supplementary Figure 1 from FGFR1 Suppresses STING-Mediated Interferon Response in Endocrine Therapy–Resistant Breast Cancer
2026 · Torbjørn Amundsen Lien, Sushil Dhakal, et al.
Figure 3 from FGFR1 Suppresses STING-Mediated Interferon Response in Endocrine Therapy–Resistant Breast Cancer
2026 · Torbjørn Amundsen Lien, Sushil Dhakal, et al.
Data from FGFR1 Suppresses STING-Mediated Interferon Response in Endocrine Therapy–Resistant Breast Cancer
2026 · Torbjørn Amundsen Lien, Sushil Dhakal, et al.
Supplementary Figure 5 from FGFR1 Suppresses STING-Mediated Interferon Response in Endocrine Therapy–Resistant Breast Cancer
2026 · Torbjørn Amundsen Lien, Sushil Dhakal, et al.
Works count: 89
Citation count: 1,671
H-index: 13
I10-index: 14
Year
Topic
Type